2016 Q1 Form 10-Q Financial Statement

#000114420416101302 Filed on May 12, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $410.0K $410.0K
YoY Change 0.0% -19.61%
% of Gross Profit
Research & Development $47.00K $43.00K
YoY Change 9.3% 79.17%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $47.00K $43.00K
YoY Change 9.3% 79.17%
Operating Profit -$454.0K -$452.0K
YoY Change 0.44% -15.83%
Interest Expense $30.00K $630.0K
YoY Change -95.24%
% of Operating Profit
Other Income/Expense, Net $34.00K $629.0K
YoY Change -94.59% -123.67%
Pretax Income -$420.0K $180.0K
YoY Change -333.33% -105.64%
Income Tax
% Of Pretax Income
Net Earnings -$420.0K $177.0K
YoY Change -337.29% -105.54%
Net Earnings / Revenue
Basic Earnings Per Share -$0.04 $0.02
Diluted Earnings Per Share -$0.04 $0.01
COMMON SHARES
Basic Shares Outstanding 10.94M shares 10.61M shares
Diluted Shares Outstanding 10.94M shares 11.87M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $550.0K $1.920M
YoY Change -71.35% 43.28%
Cash & Equivalents $545.0K $1.916M
Short-Term Investments
Other Short-Term Assets $40.00K $2.000K
YoY Change 1900.0% -33.33%
Inventory
Prepaid Expenses $31.00K
Receivables
Other Receivables
Total Short-Term Assets $590.0K $1.950M
YoY Change -69.74% 39.29%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 -$1.000K
YoY Change -100.0% -80.0%
TOTAL ASSETS
Total Short-Term Assets $590.0K $1.950M
Total Long-Term Assets $0.00 -$1.000K
Total Assets $590.0K $1.949M
YoY Change -69.73% 39.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $230.0K $384.0K
YoY Change -40.1% 149.35%
Accrued Expenses $80.00K $45.00K
YoY Change 77.78% -21.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $350.0K $1.123M
YoY Change -68.83% -80.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $350.0K $1.123M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $350.0K $1.123M
YoY Change -68.83% -80.4%
SHAREHOLDERS EQUITY
Retained Earnings -$112.0M -$110.7M
YoY Change 1.13%
Common Stock $111.0M $110.3M
YoY Change 0.61% 3.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $243.0K $826.0K
YoY Change
Total Liabilities & Shareholders Equity $588.0K $1.949M
YoY Change -69.83% 39.71%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$420.0K $177.0K
YoY Change -337.29% -105.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$500.0K -$420.0K
YoY Change 19.05% 11.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $102.0K $27.00K
YoY Change 277.78%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 100.0K $27.00K
YoY Change 270.37% -49.06%
NET CHANGE
Cash From Operating Activities -500.0K -420.0K
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities 100.0K $27.00K
Net Change In Cash -400.0K $27.00K
YoY Change -1581.48% -108.31%
FREE CASH FLOW
Cash From Operating Activities -$500.0K -$420.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
69255000 USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34000 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
629000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
407000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-454000 USD
CY2015Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
625000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-452000 USD
CY2015Q1 us-gaap Revenues
Revenues
0 USD
CY2016Q1 us-gaap Revenues
Revenues
0 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
409000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-420000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-72000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
76000 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-87000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
69153000 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41698000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41685000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111953000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111533000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1243000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1243000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
243000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
548000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
588000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1019000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
177000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43000 USD
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000 USD
CY2015Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4000 USD
CY2016Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
13000 USD
CY2015Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-499000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-418000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-397000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-391000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2307000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1916000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
102000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
27000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-36000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-17000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-15000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
102000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27000 USD
CY2016Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
545000 USD
CY2015Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
942000 USD
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10605000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11870000 shares
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1265000 shares
CY2016Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
39000 USD
CY2015Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
694000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
545000 USD
CY2016Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
39000 USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11007000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10940000 shares
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
613000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
826000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
1112000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
1019000 USD
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
9000 USD
CY2015Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
10000 USD
CY2015Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
9000 USD
CY2016Q1 us-gaap Cash
Cash
116000 CAD
CY2016Q1 us-gaap Cash
Cash
57000 USD
CY2015Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000 USD
CY2015Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000 USD
CY2015Q2 fencf Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
449000 USD
CY2016Q1 fencf Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
102000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-540000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-173000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-123000 USD
CY2015Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
69000 USD
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Use of estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that impact the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the interim condensed consolidated financial statements and the reported amounts of expense during the reporting period.&#160;Actual results could differ from those estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In the opinion of management, these unaudited interim condensed consolidated financial statements include all adjustments, which are normal and recurring in nature, necessary for the fair presentation of the Company&#8217;s financial position at March 31, 2016 and to state fairly the results for the periods presented. The most significant estimates utilized during the quarter ended March 31, 2016 included estimates necessary to value derivative instruments, disclosed in Note 4.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 fencf Stock Options Issuance Exercised
StockOptionsIssuanceExercised
14000 shares
CY2016Q1 fencf Stock Options Issuance Forfeited
StockOptionsIssuanceForfeited
10000 shares
CY2016Q1 fencf Stock Options Issuance Expired
StockOptionsIssuanceExpired
0 shares
CY2015Q4 fencf Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber
0 shares
CY2016Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2015Q4 fencf Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
1.82
CY2016Q1 fencf Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber
0 shares
CY2016Q1 fencf Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageExercisePrice
1.81
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.94
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.74
CY2016Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.32
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
13000 USD
CY2015Q4 fencf Stock Options Issuance
StockOptionsIssuance
65000 shares
CY2016Q1 fencf Stock Options Issuance
StockOptionsIssuance
40000 shares
CY2016Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 USD
CY2015Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
9000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2016Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1750000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0190 pure
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.27 pure
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2016Q1 fencf Percentage Of Common Shares Outstanding
PercentageOfCommonSharesOutstanding
0.25 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0067 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.25 pure
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17000 USD
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10940000 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11007000 shares
CY2016Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
821000 shares
CY2016Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3000 USD

Files In Submission

Name View Source Status
0001144204-16-101302-index-headers.html Edgar Link pending
0001144204-16-101302-index.html Edgar Link pending
0001144204-16-101302.txt Edgar Link pending
0001144204-16-101302-xbrl.zip Edgar Link pending
fencf-20160331.xml Edgar Link completed
fencf-20160331.xsd Edgar Link pending
fencf-20160331_cal.xml Edgar Link unprocessable
fencf-20160331_def.xml Edgar Link unprocessable
fencf-20160331_lab.xml Edgar Link unprocessable
fencf-20160331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg24.jpg Edgar Link pending
v439040_10q.htm Edgar Link pending
v439040_ex10-41.htm Edgar Link pending
v439040_ex10-42.htm Edgar Link pending
v439040_ex31-1.htm Edgar Link pending
v439040_ex31-2.htm Edgar Link pending
v439040_ex32-1.htm Edgar Link pending
v439040_ex99-1.htm Edgar Link pending